Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer

Author： Dimitrakakis C.   Keramopoulos D.   Vourli G.   Gaki V.   Bredakis N.   Keramopoulos A.  

Publisher： Informa Healthcare

ISSN： 1473-0804

Source： Climacteric, Vol.8, Iss.4, 2005-12, pp. : 342-351

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tamoxifen and proliferation of vaginal and cervical epithelium in postmenopausal women with breast cancer

By Friedrich M.   Mink D.   Villena-Heinsen C.   Astrid Woll-Hermann   Schmidt W.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 80, Iss. 2, 1998-10 ,pp. : 221-225

Elsevier

Access to resources Recommend Favorite

Anastrozole therapy for postmenopausal women with early breast cancer

By Nabholtz Jean-Marc  

Expert Review of Obstretrics and Gynecology, Vol. 2, Iss. 3, 2007-05 ,pp. : 279-291

Informa Healthcare

Access to resources Recommend Favorite

Effects of tibolone on plasma homocysteine levels in postmenopausal women

By Celik H.   Ayar A.   Tug N.   Cikim G.   Kilic N.   Parmaksiz C.  

Fertility and Sterility, Vol. 78, Iss. 2, 2002-08 ,pp. : 347-350

Elsevier

Access to resources Recommend Favorite

Ten years of treatment with tibolone 2.5 mg daily: effects on bone loss in postmenopausal women

By Rymer J.   Robinson J.   Fogelman I.  

Climacteric, Vol. 5, Iss. 4, 2002-12 ,pp. : 390-398

Informa Healthcare

Access to resources Recommend Favorite

A randomized study of the effects of tibolone and transdermal estrogen replacement therapy in postmenopausal women with uterine myomas

By Fedele L.   Bianchi S.   Raffaelli R.   Zanconato G.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 88, Iss. 1, 2000-01 ,pp. : 91-94

Elsevier

Access to resources Recommend Favorite